Glucagon-like peptide-1 receptor agonist prescribing patterns in adolescents with type 2 diabetes

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1380-1384
Number of pages5
JournalDiabetes, Obesity and Metabolism
Volume24
Issue number7
DOIs
StatePublished - Jul 2022

Bibliographical note

Funding Information:
We are grateful to Grace Christensen and Thanya Reddy for their dataset work. The work was also support in part by a grant from the National Institutes of Health's National Institute for Diabetes and Digestive and Kidney Disease (K23 DK129721).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • GLP-1 analogue
  • antidiabetic drug
  • exenatide
  • liraglutide
  • type 2 diabetes

Cite this